210 related articles for article (PubMed ID: 28298217)
21. Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells.
Larsson N; Billström R; Lilljebjörn H; Lassen C; Richter J; Ekblom M; Fioretos T
Cancer Genet Cytogenet; 2010 Jun; 199(2):89-95. PubMed ID: 20471511
[TBL] [Abstract][Full Text] [Related]
22. AML/MDS with 11q/MLL amplification show characteristic gene expression signature and interplay of DNA copy number changes.
Zatkova A; Merk S; Wendehack M; Bilban M; Muzik EM; Muradyan A; Haferlach C; Haferlach T; Wimmer K; Fonatsch C; Ullmann R
Genes Chromosomes Cancer; 2009 Jun; 48(6):510-20. PubMed ID: 19306356
[TBL] [Abstract][Full Text] [Related]
23. Gene expression profiling in MDS and AML: potential and future avenues.
Theilgaard-Mönch K; Boultwood J; Ferrari S; Giannopoulos K; Hernandez-Rivas JM; Kohlmann A; Morgan M; Porse B; Tagliafico E; Zwaan CM; Wainscoat J; Van den Heuvel-Eibrink MM; Mills K; Bullinger L
Leukemia; 2011 Jun; 25(6):909-20. PubMed ID: 21445077
[TBL] [Abstract][Full Text] [Related]
24. [Expression of homeobox gene HOXA9 in childhood acute leukemia, and its clinical significance].
Jia XH; Zhu LP; Li JC; Wang CC
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Apr; 15(4):268-72. PubMed ID: 23607948
[TBL] [Abstract][Full Text] [Related]
25. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations.
Pullarkat VA; Bueso-Ramos C; Lai R; Kroft S; Wilson CS; Pullarkat ST; Bu X; Thein M; Lee M; Brynes RK
Am J Hematol; 2003 May; 73(1):12-7. PubMed ID: 12701114
[TBL] [Abstract][Full Text] [Related]
26. Gene expression profiling in acute myeloid leukemia.
Bullinger L; Valk PJ
J Clin Oncol; 2005 Sep; 23(26):6296-305. PubMed ID: 16155012
[TBL] [Abstract][Full Text] [Related]
27. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
[TBL] [Abstract][Full Text] [Related]
28. CYP2B6 gene single nucleotide polymorphisms and leukemia susceptibility.
Yuan ZH; Liu Q; Zhang Y; Liu HX; Zhao J; Zhu P
Ann Hematol; 2011 Mar; 90(3):293-9. PubMed ID: 20878158
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
30. Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.
Lepelley P; Preudhomme C; Vanrumbeke M; Quesnel B; Cosson A; Fenaux P
Leukemia; 1994 Aug; 8(8):1342-9. PubMed ID: 8057671
[TBL] [Abstract][Full Text] [Related]
31. Ectopic expression of the homeobox gene Cdx2 is the transforming event in a mouse model of t(12;13)(p13;q12) acute myeloid leukemia.
Rawat VP; Cusan M; Deshpande A; Hiddemann W; Quintanilla-Martinez L; Humphries RK; Bohlander SK; Feuring-Buske M; Buske C
Proc Natl Acad Sci U S A; 2004 Jan; 101(3):817-22. PubMed ID: 14718672
[TBL] [Abstract][Full Text] [Related]
32. Low frequency of rearrangements of the homeobox gene HOXA9/t(7;11) in adult acute myeloid leukemia.
Kwong YL; Pang A
Genes Chromosomes Cancer; 1999 May; 25(1):70-4. PubMed ID: 10221343
[TBL] [Abstract][Full Text] [Related]
33. Gene expression analysis reveals HOX gene upregulation in trisomy 8 AML.
Kok CH; Brown AL; Ekert PG; D'Andrea RJ
Leukemia; 2010 Jun; 24(6):1239-43. PubMed ID: 20428200
[No Abstract] [Full Text] [Related]
34. Identification of new markers discriminating between myeloid and lymphoid acute leukemia.
Haouas H; Haouas S; Uzan G; Hafsia A
Hematology; 2010 Aug; 15(4):193-203. PubMed ID: 20670477
[TBL] [Abstract][Full Text] [Related]
35. Profiling three-dimensional nuclear telomeric architecture of myelodysplastic syndromes and acute myeloid leukemia defines patient subgroups.
Gadji M; Adebayo Awe J; Rodrigues P; Kumar R; Houston DS; Klewes L; Dièye TN; Rego EM; Passetto RF; de Oliveira FM; Mai S
Clin Cancer Res; 2012 Jun; 18(12):3293-304. PubMed ID: 22539801
[TBL] [Abstract][Full Text] [Related]
36. Molecular cytogenetic profiling of complex karyotypes in primary myelodysplastic syndromes and acute myeloid leukemia.
Trost D; Hildebrandt B; Beier M; Müller N; Germing U; Royer-Pokora B
Cancer Genet Cytogenet; 2006 Feb; 165(1):51-63. PubMed ID: 16490597
[TBL] [Abstract][Full Text] [Related]
37. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
38. GEP analysis validates high risk MDS and acute myeloid leukemia post MDS mice models and highlights novel dysregulated pathways.
Guerenne L; Beurlet S; Said M; Gorombei P; Le Pogam C; Guidez F; de la Grange P; Omidvar N; Vanneaux V; Mills K; Mufti GJ; Sarda-Mantel L; Noguera ME; Pla M; Fenaux P; Padua RA; Chomienne C; Krief P
J Hematol Oncol; 2016 Jan; 9():5. PubMed ID: 26817437
[TBL] [Abstract][Full Text] [Related]
39. Role of ASXL1 and TP53 mutations in the molecular classification and prognosis of acute myeloid leukemias with myelodysplasia-related changes.
Devillier R; Mansat-De Mas V; Gelsi-Boyer V; Demur C; Murati A; Corre J; Prebet T; Bertoli S; Brecqueville M; Arnoulet C; Recher C; Vey N; Mozziconacci MJ; Delabesse E; Birnbaum D
Oncotarget; 2015 Apr; 6(10):8388-96. PubMed ID: 25860933
[TBL] [Abstract][Full Text] [Related]
40. Identification and validation of the dopamine agonist bromocriptine as a novel therapy for high-risk myelodysplastic syndromes and secondary acute myeloid leukemia.
Liberante FG; Pouryahya T; McMullin MF; Zhang SD; Mills KI
Oncotarget; 2016 Feb; 7(6):6609-19. PubMed ID: 26735888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
